Item Type | Name |
Concept
|
Age Factors
|
Concept
|
Fabry Disease
|
Concept
|
Aldosterone
|
Concept
|
Australia
|
Concept
|
Algorithms
|
Concept
|
Biphenyl Compounds
|
Concept
|
Blood Flow Velocity
|
Concept
|
Blood Pressure
|
Concept
|
Alleles
|
Concept
|
Administration, Oral
|
Concept
|
Albuminuria
|
Concept
|
Alcohol Drinking
|
Concept
|
Calcium Phosphates
|
Concept
|
Intracranial Aneurysm
|
Concept
|
Angiotensin-Converting Enzyme Inhibitors
|
Concept
|
Chromosomes, Human, Pair 11
|
Concept
|
Chromosomes, Human, Pair 2
|
Concept
|
Analysis of Variance
|
Concept
|
Anthropometry
|
Concept
|
Atenolol
|
Concept
|
Bayes Theorem
|
Concept
|
Benzoates
|
Concept
|
Body Height
|
Concept
|
Calcium Oxalate
|
Concept
|
Attitude to Health
|
Concept
|
Blood Glucose
|
Concept
|
Bilirubin
|
Concept
|
Body Weight
|
Concept
|
Career Mobility
|
Concept
|
Evaluation Studies as Topic
|
Concept
|
Cerebral Angiography
|
Concept
|
Chlorthalidone
|
Concept
|
Chromosomes, Human, Pair 12
|
Concept
|
Blood Pressure Determination
|
Concept
|
Career Choice
|
Concept
|
Creatinine
|
Concept
|
Coronary Artery Disease
|
Concept
|
Diabetes Mellitus, Type 2
|
Concept
|
Cysts
|
Concept
|
Education, Medical
|
Concept
|
DNA Mutational Analysis
|
Concept
|
Echocardiography
|
Concept
|
Gene Frequency
|
Concept
|
Hypertension, Renovascular
|
Concept
|
Image Enhancement
|
Concept
|
Chromosomes, Human, Pair 17
|
Concept
|
Clinical Protocols
|
Concept
|
Diagnostic Imaging
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Double-Blind Method
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Faculty, Medical
|
Concept
|
Gene Expression Regulation
|
Concept
|
Georgia
|
Concept
|
Glomerular Filtration Rate
|
Concept
|
Family Relations
|
Concept
|
Fasting
|
Concept
|
Kidney Diseases
|
Concept
|
Obesity
|
Concept
|
Hormone Antagonists
|
Concept
|
Drug Combinations
|
Concept
|
Efficiency
|
Concept
|
Enalapril
|
Concept
|
Fluorescent Antibody Technique
|
Concept
|
Image Interpretation, Computer-Assisted
|
Concept
|
Gadolinium
|
Concept
|
Peptidyl-Dipeptidase A
|
Concept
|
Mentors
|
Concept
|
Hypertension, Renal
|
Concept
|
Mosaicism
|
Concept
|
Pharmacogenetics
|
Concept
|
Liver Function Tests
|
Concept
|
Metoprolol
|
Concept
|
Mice, Transgenic
|
Concept
|
Medical History Taking
|
Concept
|
Organ Size
|
Concept
|
Morbidity
|
Concept
|
Mutation
|
Concept
|
Iothalamic Acid
|
Concept
|
Kidney Function Tests
|
Concept
|
Pedigree
|
Concept
|
Pattern Recognition, Automated
|
Concept
|
Nephritis, Hereditary
|
Concept
|
Polymorphism, Genetic
|
Concept
|
Probability
|
Concept
|
Forecasting
|
Concept
|
Regression Analysis
|
Concept
|
Renal Circulation
|
Concept
|
Haplotypes
|
Concept
|
Registries
|
Concept
|
Risk Factors
|
Concept
|
Pseudouridine
|
Concept
|
Pulsatile Flow
|
Concept
|
ROC Curve
|
Concept
|
Cohort Studies
|
Concept
|
Polycystic Kidney Diseases
|
Concept
|
Kininogens
|
Concept
|
Risk
|
Concept
|
Sensitivity and Specificity
|
Concept
|
Hemodynamics
|
Concept
|
Humans
|
Concept
|
Body Mass Index
|
Concept
|
Incidence
|
Concept
|
Cluster Analysis
|
Concept
|
Linear Models
|
Concept
|
Single-Blind Method
|
Concept
|
Tomography, X-Ray Computed
|
Concept
|
Tetrazoles
|
Concept
|
Genome
|
Concept
|
Ultrasonography
|
Concept
|
Triglycerides
|
Concept
|
Practice Guidelines as Topic
|
Concept
|
Genetic Variation
|
Concept
|
Kidney Failure, Chronic
|
Concept
|
Kidney Glomerulus
|
Concept
|
Multicenter Studies as Topic
|
Concept
|
Lipase
|
Concept
|
Gene Rearrangement
|
Concept
|
Proportional Hazards Models
|
Concept
|
Randomized Controlled Trials as Topic
|
Concept
|
Risk Assessment
|
Concept
|
Blood Pressure Monitoring, Ambulatory
|
Concept
|
Gene Duplication
|
Concept
|
Cell Adhesion Molecules
|
Concept
|
Up-Regulation
|
Concept
|
Prevalence
|
Concept
|
Observer Variation
|
Concept
|
Antigens, CD
|
Concept
|
Mortality
|
Concept
|
Chi-Square Distribution
|
Concept
|
Least-Squares Analysis
|
Concept
|
Rats, Sprague-Dawley
|
Concept
|
Case-Control Studies
|
Concept
|
Sequence Analysis, DNA
|
Concept
|
Methylation
|
Concept
|
Treatment Outcome
|
Concept
|
Hypertrophy, Left Ventricular
|
Concept
|
Polycystic Kidney, Autosomal Recessive
|
Concept
|
Bisoprolol
|
Concept
|
Amlodipine
|
Concept
|
Gene Deletion
|
Concept
|
Mice, Knockout
|
Concept
|
Lisinopril
|
Concept
|
Sample Size
|
Concept
|
Glucose Intolerance
|
Concept
|
Receptors, Adrenergic, beta-2
|
Concept
|
Databases as Topic
|
Concept
|
Cytochrome P-450 CYP2D6
|
Concept
|
Mutation, Missense
|
Concept
|
Metabolic Syndrome
|
Concept
|
Cross-Over Studies
|
Concept
|
G-Protein-Coupled Receptor Kinase 4
|
Concept
|
Lipopolysaccharide Receptors
|
Concept
|
Cardiac-Gated Imaging Techniques
|
Concept
|
Reactive Oxygen Species
|
Concept
|
Genetic Association Studies
|
Concept
|
Molecular Diagnostic Techniques
|
Concept
|
Early Diagnosis
|
Concept
|
Consensus
|
Concept
|
Positron-Emission Tomography
|
Concept
|
Atherosclerosis
|
Concept
|
Proteomics
|
Concept
|
Renal Insufficiency, Chronic
|
Concept
|
Area Under Curve
|
Concept
|
Microscopy, Confocal
|
Concept
|
Parents
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
Concept
|
Heterotrimeric GTP-Binding Proteins
|
Concept
|
Interleukin-18
|
Concept
|
Gene Expression Profiling
|
Concept
|
Endpoint Determination
|
Concept
|
Retinal Dehydrogenase
|
Concept
|
Mice
|
Concept
|
Renin-Angiotensin System
|
Concept
|
Surveys and Questionnaires
|
Concept
|
Radioimmunoassay
|
Concept
|
Severity of Illness Index
|
Concept
|
Renin
|
Concept
|
Cystatin C
|
Concept
|
Rats
|
Concept
|
Obesity, Abdominal
|
Concept
|
High-Throughput Nucleotide Sequencing
|
Concept
|
Genotyping Techniques
|
Concept
|
Sex Factors
|
Concept
|
Medication Therapy Management
|
Concept
|
Receptor-Like Protein Tyrosine Phosphatases, Class 2
|
Concept
|
Multivariate Analysis
|
Concept
|
Logistic Models
|
Concept
|
Survival Analysis
|
Concept
|
DNA Copy Number Variations
|
Concept
|
Caregivers
|
Concept
|
Kidney Diseases, Cystic
|
Concept
|
Tuberous Sclerosis
|
Concept
|
Meta-Analysis as Topic
|
Concept
|
Reproducibility of Results
|
Concept
|
Minor Histocompatibility Antigens
|
Concept
|
Linkage Disequilibrium
|
Concept
|
Survival Rate
|
Concept
|
Receptors, Adrenergic, beta-1
|
Concept
|
Odds Ratio
|
Concept
|
Polymerase Chain Reaction
|
Concept
|
Urinalysis
|
Concept
|
Polycystic Kidney, Autosomal Dominant
|
Concept
|
Chemokine CCL2
|
Concept
|
NADPH Oxidases
|
Concept
|
Imaging, Three-Dimensional
|
Concept
|
Gene Dosage
|
Concept
|
Statistics, Nonparametric
|
Concept
|
Genetic Heterogeneity
|
Concept
|
Transcriptome
|
Concept
|
Genome-Wide Association Study
|
Concept
|
AMP-Activated Protein Kinases
|
Concept
|
Vascular Stiffness
|
Concept
|
Renal Insufficiency
|
Concept
|
Kaplan-Meier Estimate
|
Concept
|
Plasma Membrane Calcium-Transporting ATPases
|
Concept
|
Healthcare Disparities
|
Concept
|
Nephrogenic Fibrosing Dermopathy
|
Concept
|
Chromosomes, Human, Pair 16
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Diabetes Mellitus
|
Concept
|
Diastole
|
Concept
|
Disease Models, Animal
|
Concept
|
Drug Administration Schedule
|
Concept
|
Epoxide Hydrolases
|
Concept
|
Florida
|
Concept
|
Follow-Up Studies
|
Concept
|
Genetic Testing
|
Concept
|
Genotype
|
Concept
|
Health Personnel
|
Concept
|
Heart Rate
|
Concept
|
Hepatomegaly
|
Concept
|
Hyperglycemia
|
Concept
|
Kidney Calculi
|
Concept
|
Longitudinal Studies
|
Concept
|
Magnetic Resonance Imaging
|
Concept
|
Pain Measurement
|
Concept
|
Predictive Value of Tests
|
Concept
|
Prospective Studies
|
Concept
|
Rats, Mutant Strains
|
Concept
|
Receptors, Adrenergic, beta
|
Concept
|
Renal Artery Obstruction
|
Concept
|
Retrospective Studies
|
Concept
|
Systole
|
Concept
|
Gastric Bypass
|
Concept
|
Databases, Factual
|
Concept
|
Focus Groups
|
Concept
|
Cost of Illness
|
Concept
|
Age of Onset
|
Concept
|
Electrophoresis, Capillary
|
Concept
|
Losartan
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Polymorphism, Single Nucleotide
|
Concept
|
Genomics
|
Concept
|
MicroRNAs
|
Concept
|
Protein Kinase Inhibitors
|
Concept
|
Estrogen Receptor alpha
|
Concept
|
Overweight
|
Concept
|
G-Protein-Coupled Receptor Kinase 2
|
Concept
|
G-Protein-Coupled Receptor Kinase 5
|
Concept
|
Genetic Loci
|
Concept
|
GPI-Linked Proteins
|
Concept
|
Signal-To-Noise Ratio
|
Concept
|
Patient Safety
|
Academic Article
|
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
|
Academic Article
|
Blood pressure in early autosomal dominant polycystic kidney disease.
|
Academic Article
|
Novel methodology to evaluate renal cysts in polycystic kidney disease.
|
Academic Article
|
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic.
|
Academic Article
|
Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide.
|
Academic Article
|
PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
|
Academic Article
|
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
|
Academic Article
|
WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic.
|
Academic Article
|
Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide.
|
Academic Article
|
A Physiologic Approach to the Pharmacogenomics of Hypertension.
|
Academic Article
|
Nephrology fellows show consistent use of, and improved knowledge from, a nephrologist-programmed teaching instrument.
|
Academic Article
|
Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.
|
Academic Article
|
PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
|
Academic Article
|
TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives.
|
Academic Article
|
Volume progression in polycystic kidney disease.
|
Academic Article
|
Kininogen gene (KNG) variation has a consistent effect on aldosterone response to antihypertensive drug therapy: the GERA study.
|
Academic Article
|
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
|
Academic Article
|
Angiotensin blockade in late autosomal dominant polycystic kidney disease.
|
Academic Article
|
Urate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with hypertension.
|
Academic Article
|
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.
|
Academic Article
|
Novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease.
|
Academic Article
|
Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol.
|
Academic Article
|
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial.
|
Academic Article
|
Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease.
|
Academic Article
|
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data.
|
Academic Article
|
Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD.
|
Academic Article
|
Imaging approaches to patients with polycystic kidney disease.
|
Academic Article
|
Polycystic kidney disease: The cadence of kidney growth in ADPKD.
|
Academic Article
|
The spectrum of autosomal dominant polycystic kidney disease in children and adolescents.
|
Academic Article
|
Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.
|
Academic Article
|
Urine peptidome analysis predicts risk of end-stage renal disease and reveals proteolytic pathways involved in autosomal dominant polycystic kidney disease progression.
|
Academic Article
|
Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.
|
Academic Article
|
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.
|
Academic Article
|
Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial.
|
Academic Article
|
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.
|
Academic Article
|
Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
|
Academic Article
|
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.
|
Academic Article
|
Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide.
|
Academic Article
|
Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols.
|
Academic Article
|
Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment.
|
Academic Article
|
Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy.
|
Academic Article
|
Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort.
|
Academic Article
|
Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study.
|
Academic Article
|
Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated Hypertension.
|
Academic Article
|
Effect of plasma MicroRNA on antihypertensive response to beta blockers in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studies.
|
Academic Article
|
The future of pharmacogenetics in the treatment of hypertension.
|
Academic Article
|
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.
|
Academic Article
|
Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.
|
Academic Article
|
Genomic Association Analysis Reveals Variants Associated With Blood Pressure Response to Beta-Blockers in European Americans.
|
Academic Article
|
Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
ß2 -Adrenergic Receptor Gene Affects the Heart Rate Response of ß-Blockers: Evidence From 3 Clinical Studies.
|
Academic Article
|
Genome-Wide Meta-Analysis of Blood Pressure Response to ß1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies).
|
Academic Article
|
Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers.
|
Academic Article
|
Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response.
|
Academic Article
|
Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients.
|
Academic Article
|
Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease.
|
Academic Article
|
A Practical Approach to Polycystic Liver Disease.
|
Academic Article
|
Response to: Heterogeneous Treatment Response by Race Cannot Be Claimed in the Absence of Evidence.
|
Academic Article
|
Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review.
|
Academic Article
|
Polycystins, ADPKD, and Cardiovascular Disease.
|
Academic Article
|
Sorting nexin 1 loss results in increased oxidative stress and hypertension.
|
Academic Article
|
Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey.
|
Academic Article
|
Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations.
|
Academic Article
|
A Randomized Trial of Modified-Release Versus Immediate-Release Tolvaptan in ADPKD.
|
Academic Article
|
The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.
|
Academic Article
|
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.
|
Academic Article
|
Advancing Nephrology: Division Leaders Advise ASN.
|
Academic Article
|
Mineral bone disease in autosomal dominant polycystic kidney disease.
|
Academic Article
|
'A sword of Damocles': patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study.
|
Academic Article
|
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity Scores.
|
Academic Article
|
Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
Race-Specific Comparisons of Antihypertensive and Metabolic Effects of Hydrochlorothiazide and Chlorthalidone.
|
Academic Article
|
Sex Differences of Kidney Stone Urine Risk Factors after Roux-en-Y Gastric Bypass.
|
Academic Article
|
The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial.
|
Academic Article
|
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review.
|
Academic Article
|
Tolvaptan in ADPKD Patients With Very Low Kidney Function.
|
Academic Article
|
Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies.
|
Academic Article
|
Agreement of Food Records and 24-Hour Urine Studies in Clinical Practice.
|
Academic Article
|
Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients.
|
Academic Article
|
PKD1 Compared With PKD2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies.
|
Academic Article
|
Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report.
|
Academic Article
|
Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study.
|
Academic Article
|
Emerging Role of Clinical Genetics in CKD.
|
Academic Article
|
Polycystic Kidney Disease in the Real World.
|
Academic Article
|
Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course.
|
Academic Article
|
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.
|
Academic Article
|
Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States.
|
Academic Article
|
Utilization of Cystatin C in the Outpatient Setting.
|
Academic Article
|
Influence of Genetic West African Ancestry on Metabolomics among Hypertensive Patients.
|
Academic Article
|
Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients.
|
Academic Article
|
Measuring Copeptin, a surrogate for Vasopressin in Patients with Hypertension - Can it identify those who are Volume Responsive?
|
Academic Article
|
Effects of Bardoxolone Methyl in Alport Syndrome.
|
Academic Article
|
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
|
Academic Article
|
The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD.
|
Academic Article
|
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation.
|
Concept
|
Patient Reported Outcome Measures
|
Concept
|
Lipocalin-2
|
Concept
|
Pharmacogenomic Variants
|
Concept
|
Pharmacogenomic Testing
|
Concept
|
Nephrologists
|
Concept
|
Circulating MicroRNA
|
Concept
|
DCC Receptor
|
Concept
|
Bestrophins
|
Concept
|
Arterial Pressure
|
Concept
|
WNK Lysine-Deficient Protein Kinase 1
|
Concept
|
Patient Acuity
|
Concept
|
CRISPR-Cas Systems
|
Concept
|
Patient Outcome Assessment
|
Concept
|
Antidiuretic Hormone Receptor Antagonists
|
Concept
|
Observational Studies as Topic
|
Academic Article
|
Intracranial Aneurysms in ADPKD: How Far Have We Come?
|
Academic Article
|
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD.
|
Academic Article
|
All Patients with ADPKD Should Undergo Screening for Intracranial Aneurysms: COMMENTARY.
|
Academic Article
|
Pregnancy in Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
Magnetic resonance imaging preprocessing and radiomic features for classification of autosomal dominant polycystic kidney disease genotype.
|
Academic Article
|
Cardiac Localized Polycystin-2 plays a Functional Role in Natriuretic Peptide Production and its Absence Contributes to Hypertension.
|
Academic Article
|
Circulating microRNA Biomarkers of Thiazide Response in Hypertension.
|